Selected research
Industry Growth & Trends
Global Pipeline Embolization Device (PED) Industry Growth and Trends Forecast to 2032
Market perspective
The global Pipeline Embolization Device (PED) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Pipeline Embolization Device (PED) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Pipeline Embolization Device (PED) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pipeline Embolization Device (PED) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Pipeline Embolization Device (PED) include Ascendis Health, Balt Extrusion, Boston Scientific, Codman, Evasc, Microvention, Phenox GmbH, Accumedical and ZYLOX-TONBRIDGE, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Pipeline Embolization Device (PED) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Pipeline Embolization Device (PED) market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pipeline Embolization Device (PED) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pipeline Embolization Device (PED).
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Pipeline Embolization Device (PED) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Pipeline Embolization Device (PED) Market by Company
Ascendis Health
Balt Extrusion
Boston Scientific
Codman
Evasc
Microvention
Phenox GmbH
Accumedical
ZYLOX-TONBRIDGE
Medtronic
Johnson & Johnson
Stryker Corporation
MicroPort
Pipeline Embolization Device (PED) Segment by Type
48 Alloy Wire Braided
64 Alloy Wire Braided
Other
Pipeline Embolization Device (PED) Segment by Application
Intracranial Aneurysm Treatment
Neurovascular Abnormal Embolization Treatment (Arteriovenous Malformation, etc.)
Other
Pipeline Embolization Device (PED) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pipeline Embolization Device (PED) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pipeline Embolization Device (PED) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pipeline Embolization Device (PED).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pipeline Embolization Device (PED) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Pipeline Embolization Device (PED) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 48 Alloy Wire Braided
- 64 Alloy Wire Braided
- Other
Applications
- Intracranial Aneurysm Treatment
- Neurovascular Abnormal Embolization Treatment (Arteriovenous Malformation, etc.)
- Other
Companies covered
- Ascendis Health
- Balt Extrusion
- Boston Scientific
- Codman
- Evasc
- Microvention
- Phenox GmbH
- Accumedical
- ZYLOX-TONBRIDGE
- Medtronic
- Johnson & Johnson
- Stryker Corporation
- MicroPort
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Pipeline Embolization Device (PED) Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Pipeline Embolization Device (PED) Sales Estimates and Forecasts (2021-2032)
- 1.3 Pipeline Embolization Device (PED) Market by Type
- 1.3.1 48 Alloy Wire Braided
- 1.3.2 64 Alloy Wire Braided
- 1.3.3 Other
- 1.4 Global Pipeline Embolization Device (PED) Market Size by Type
- 1.4.1 Global Pipeline Embolization Device (PED) Market Size Overview by Type (2021-2032)
- 1.4.2 Global Pipeline Embolization Device (PED) Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Pipeline Embolization Device (PED) Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Pipeline Embolization Device (PED) Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Pipeline Embolization Device (PED) Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Pipeline Embolization Device (PED) Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Pipeline Embolization Device (PED) Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Pipeline Embolization Device (PED) Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Pipeline Embolization Device (PED) Industry Trends
- 2.2 Pipeline Embolization Device (PED) Industry Drivers
- 2.3 Pipeline Embolization Device (PED) Industry Opportunities and Challenges
- 2.4 Pipeline Embolization Device (PED) Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Pipeline Embolization Device (PED) Revenue (2021-2026)
- 3.2 Global Top Players by Pipeline Embolization Device (PED) Sales (2021-2026)
- 3.3 Global Top Players by Pipeline Embolization Device (PED) Price (2021-2026)
- 3.4 Global Pipeline Embolization Device (PED) Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Pipeline Embolization Device (PED) Major Company Production Sites & Headquarters
- 3.6 Global Pipeline Embolization Device (PED) Company, Product Type & Application
- 3.7 Global Pipeline Embolization Device (PED) Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Pipeline Embolization Device (PED) Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Pipeline Embolization Device (PED) Players Market Share by Revenue in 2025
- 3.8.3 2025 Pipeline Embolization Device (PED) Tier 1, Tier 2, and Tier 3
4 Pipeline Embolization Device (PED) Regional Status and Outlook
- 4.1 Global Pipeline Embolization Device (PED) Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Pipeline Embolization Device (PED) Historic Market Size by Region
- 4.2.1 Global Pipeline Embolization Device (PED) Sales in Volume by Region (2021-2026)
- 4.2.2 Global Pipeline Embolization Device (PED) Sales in Value by Region (2021-2026)
- 4.2.3 Global Pipeline Embolization Device (PED) Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Pipeline Embolization Device (PED) Forecasted Market Size by Region
- 4.3.1 Global Pipeline Embolization Device (PED) Sales in Volume by Region (2027-2032)
- 4.3.2 Global Pipeline Embolization Device (PED) Sales in Value by Region (2027-2032)
- 4.3.3 Global Pipeline Embolization Device (PED) Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Pipeline Embolization Device (PED) by Application
- 5.1 Pipeline Embolization Device (PED) Market by Application
- 5.1.1 Intracranial Aneurysm Treatment
- 5.1.2 Neurovascular Abnormal Embolization Treatment (Arteriovenous Malformation, etc.)
- 5.1.3 Other
- 5.2 Global Pipeline Embolization Device (PED) Market Size by Application
- 5.2.1 Global Pipeline Embolization Device (PED) Market Size Overview by Application (2021-2032)
- 5.2.2 Global Pipeline Embolization Device (PED) Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Pipeline Embolization Device (PED) Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Pipeline Embolization Device (PED) Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Pipeline Embolization Device (PED) Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Pipeline Embolization Device (PED) Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Pipeline Embolization Device (PED) Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Pipeline Embolization Device (PED) Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Ascendis Health
- 6.1.1 Ascendis Health Company Information
- 6.1.2 Ascendis Health Business Overview
- 6.1.3 Ascendis Health Pipeline Embolization Device (PED) Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Ascendis Health Pipeline Embolization Device (PED) Product Portfolio
- 6.1.5 Ascendis Health Recent Developments
- 6.2 Balt Extrusion
- 6.2.1 Balt Extrusion Company Information
- 6.2.2 Balt Extrusion Business Overview
- 6.2.3 Balt Extrusion Pipeline Embolization Device (PED) Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Balt Extrusion Pipeline Embolization Device (PED) Product Portfolio
- 6.2.5 Balt Extrusion Recent Developments
- 6.3 Boston Scientific
- 6.3.1 Boston Scientific Company Information
- 6.3.2 Boston Scientific Business Overview
- 6.3.3 Boston Scientific Pipeline Embolization Device (PED) Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Boston Scientific Pipeline Embolization Device (PED) Product Portfolio
- 6.3.5 Boston Scientific Recent Developments
- 6.4 Codman
- 6.4.1 Codman Company Information
- 6.4.2 Codman Business Overview
- 6.4.3 Codman Pipeline Embolization Device (PED) Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Codman Pipeline Embolization Device (PED) Product Portfolio
- 6.4.5 Codman Recent Developments
- 6.5 Evasc
- 6.5.1 Evasc Company Information
- 6.5.2 Evasc Business Overview
- 6.5.3 Evasc Pipeline Embolization Device (PED) Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Evasc Pipeline Embolization Device (PED) Product Portfolio
- 6.5.5 Evasc Recent Developments
- 6.6 Microvention
- 6.6.1 Microvention Company Information
- 6.6.2 Microvention Business Overview
- 6.6.3 Microvention Pipeline Embolization Device (PED) Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Microvention Pipeline Embolization Device (PED) Product Portfolio
- 6.6.5 Microvention Recent Developments
- 6.7 Phenox GmbH
- 6.7.1 Phenox GmbH Company Information
- 6.7.2 Phenox GmbH Business Overview
- 6.7.3 Phenox GmbH Pipeline Embolization Device (PED) Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Phenox GmbH Pipeline Embolization Device (PED) Product Portfolio
- 6.7.5 Phenox GmbH Recent Developments
- 6.8 Accumedical
- 6.8.1 Accumedical Company Information
- 6.8.2 Accumedical Business Overview
- 6.8.3 Accumedical Pipeline Embolization Device (PED) Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Accumedical Pipeline Embolization Device (PED) Product Portfolio
- 6.8.5 Accumedical Recent Developments
- 6.9 ZYLOX-TONBRIDGE
- 6.9.1 ZYLOX-TONBRIDGE Company Information
- 6.9.2 ZYLOX-TONBRIDGE Business Overview
- 6.9.3 ZYLOX-TONBRIDGE Pipeline Embolization Device (PED) Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 ZYLOX-TONBRIDGE Pipeline Embolization Device (PED) Product Portfolio
- 6.9.5 ZYLOX-TONBRIDGE Recent Developments
- 6.10 Medtronic
- 6.10.1 Medtronic Company Information
- 6.10.2 Medtronic Business Overview
- 6.10.3 Medtronic Pipeline Embolization Device (PED) Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Medtronic Pipeline Embolization Device (PED) Product Portfolio
- 6.10.5 Medtronic Recent Developments
- 6.11 Johnson & Johnson
- 6.11.1 Johnson & Johnson Company Information
- 6.11.2 Johnson & Johnson Business Overview
- 6.11.3 Johnson & Johnson Pipeline Embolization Device (PED) Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Johnson & Johnson Pipeline Embolization Device (PED) Product Portfolio
- 6.11.5 Johnson & Johnson Recent Developments
- 6.12 Stryker Corporation
- 6.12.1 Stryker Corporation Company Information
- 6.12.2 Stryker Corporation Business Overview
- 6.12.3 Stryker Corporation Pipeline Embolization Device (PED) Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Stryker Corporation Pipeline Embolization Device (PED) Product Portfolio
- 6.12.5 Stryker Corporation Recent Developments
- 6.13 MicroPort
- 6.13.1 MicroPort Company Information
- 6.13.2 MicroPort Business Overview
- 6.13.3 MicroPort Pipeline Embolization Device (PED) Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 MicroPort Pipeline Embolization Device (PED) Product Portfolio
- 6.13.5 MicroPort Recent Developments
7 North America by Country
- 7.1 North America Pipeline Embolization Device (PED) Sales by Country
- 7.1.1 North America Pipeline Embolization Device (PED) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Pipeline Embolization Device (PED) Sales by Country (2021-2026)
- 7.1.3 North America Pipeline Embolization Device (PED) Sales Forecast by Country (2027-2032)
- 7.2 North America Pipeline Embolization Device (PED) Market Size by Country
- 7.2.1 North America Pipeline Embolization Device (PED) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Pipeline Embolization Device (PED) Market Size by Country (2021-2026)
- 7.2.3 North America Pipeline Embolization Device (PED) Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Pipeline Embolization Device (PED) Sales by Country
- 8.1.1 Europe Pipeline Embolization Device (PED) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Pipeline Embolization Device (PED) Sales by Country (2021-2026)
- 8.1.3 Europe Pipeline Embolization Device (PED) Sales Forecast by Country (2027-2032)
- 8.2 Europe Pipeline Embolization Device (PED) Market Size by Country
- 8.2.1 Europe Pipeline Embolization Device (PED) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Pipeline Embolization Device (PED) Market Size by Country (2021-2026)
- 8.2.3 Europe Pipeline Embolization Device (PED) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Pipeline Embolization Device (PED) Sales by Country
- 9.1.1 Asia-Pacific Pipeline Embolization Device (PED) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Pipeline Embolization Device (PED) Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Pipeline Embolization Device (PED) Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Pipeline Embolization Device (PED) Market Size by Country
- 9.2.1 Asia-Pacific Pipeline Embolization Device (PED) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Pipeline Embolization Device (PED) Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Pipeline Embolization Device (PED) Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Pipeline Embolization Device (PED) Sales by Country
- 10.1.1 South America Pipeline Embolization Device (PED) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Pipeline Embolization Device (PED) Sales by Country (2021-2026)
- 10.1.3 South America Pipeline Embolization Device (PED) Sales Forecast by Country (2027-2032)
- 10.2 South America Pipeline Embolization Device (PED) Market Size by Country
- 10.2.1 South America Pipeline Embolization Device (PED) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Pipeline Embolization Device (PED) Market Size by Country (2021-2026)
- 10.2.3 South America Pipeline Embolization Device (PED) Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Pipeline Embolization Device (PED) Sales by Country
- 11.1.1 Middle East and Africa Pipeline Embolization Device (PED) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Pipeline Embolization Device (PED) Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Pipeline Embolization Device (PED) Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Pipeline Embolization Device (PED) Market Size by Country
- 11.2.1 Middle East and Africa Pipeline Embolization Device (PED) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Pipeline Embolization Device (PED) Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Pipeline Embolization Device (PED) Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Pipeline Embolization Device (PED) Value Chain Analysis
- 12.1.1 Pipeline Embolization Device (PED) Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Pipeline Embolization Device (PED) Production Mode & Process
- 12.2 Pipeline Embolization Device (PED) Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Pipeline Embolization Device (PED) Distributors
- 12.2.3 Pipeline Embolization Device (PED) Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst